A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(70 sites)

United States

Research Site, Newark, Delaware

Research Site, Washington D.C., District of Columbia

Research Site, Fairway, Kansas

Research Site, North Shores, Michigan

Research Site, New York, New York